Abstract
In HORIZONS-AMI, an industry-funded, prospective, open-label, randomized, international trial of bivalirudin versus unfractionated heparin plus a
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
